KIORA PHARMACEUTICALS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.4 USD | -0.90% |
|
-0.90% | -6.41% |
| Jul. 02 | Kiora Pharmaceuticals, Inc. Announces Board and Committee Changes | CI |
| Jun. 25 | Kiora Pharmaceuticals Appoints Roger A. Goldberg to its Scientific Advisory Board | CI |
Chart calendar Kiora Pharmaceuticals, Inc.
bdfccb93de827c739f0aa9fae83ce.XJsyCrp0QQEOwrD9Q8C2AYVgos2NwjWmG31PXMJ-hrs.cfQDbYNHKSxRpOC0cZb-bfU40qTi93jNSRsfObI08eJl3mc_iwA5SkGd9Q~51d7e17d0e2c983280da4147436b7910
Upcoming events on Kiora Pharmaceuticals, Inc.
Past events on Kiora Pharmaceuticals, Inc.
| 2024-05-30 02:45 pm | Lytham Partners Spring Investor Conference |
| 2024-05-22 03:00 pm | WeBull Corporate Connect Biotech Investment Conference |
| 2024-05-14 01:00 pm | Citizens JMP Life Sciences Conference |
| 2024-05-10 07:00 am | Q1 2024 Earnings Release |
| 2024-05-05 05:00 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-01 01:00 pm | Annual General Meeting |
| 2024-04-18 02:30 pm | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 2024-04-11 10:15 am | Needham Healthcare Conference |
| 2024-03-25 07:00 am | Q4 2023 Earnings Release |
| 2024-01-31 05:30 pm | Business Update Call |
| 2023-11-04 12:15 pm | American Academy Of Ophthalmology Meeting |
| 2023-10-17 07:00 am | Lytham Partners Fall Investor Conference |
| 2023-08-31 12:00 pm | Extraordinary Shareholders Meeting |
| 2023-08-16 12:00 am | HCW Ophthalmology Virtual Conference |
| 2023-08-08 07:00 am | Q2 2023 Earnings Release |
| 2023-06-22 02:00 pm | OTC Life Science Investor Forum |
| 2023-06-21 10:00 am | Annual General Meeting |
| 2023-06-20 10:00 am | Maxim Group Virtual Healthcare Conference |
| 2023-05-01 06:26 pm | American Society of Neuroradiology Meeting |
| 2023-04-27 01:45 pm | Association for Research in Vision and Ophthalmology Meeting - Poster No 5444 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,69 2,69 0% | 0,01 0,03 -64% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 16,5 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,11 -7,43 4.38% | -8,21 -9,44 13.01% | -16,9 -11,3 -49.59% | -12,3 -13,0 5.59% | -12,6 -13,3 5.33% | 3,76 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,00 -7,32 4.35% | -8,08 -9,40 14.08% | -16,7 -11,0 -51.14% | -13,7 -14,5 5.22% | -12,4 -13,2 6.18% | 4,01 |
|
Net income Million USD | Released Forecast Spread | -7,10 -7,32 3.05% | -8,09 -9,21 12.13% | -16,4 -11,0 -48.38% | -13,6 -14,5 6% | -13,0 -13,4 2.79% | 4,01 |
|
EPS USD | Released Forecast Spread | -803 -752 -6.7% | -637 -727 12.38% | -637 -446 -42.74% | -167 -121 -37.82% | -24,2 -23,3 -3.99% | 0,93 |
| Announcement Date | 04/03/20 | 25/03/21 | 15/04/22 | 23/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 16,0 8,00 100% | 0,00 | 0,00 | 0,50 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,57 -2,98 -19.6% | -2,40 -2,60 7.61% | -3,70 -2,68 -38.17% | -2,64 -3,36 21.67% | -1,92 -3,11 38.42% | -2,63 -2,55 -3.26% | -5,92 -2,70 -119.59% | -2,12 -2,83 25.06% | 13,2 5,40 144.81% | -3,14 | -3,20 | -3,12 | -3,93 | -4,07 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,57 -2,98 -19.45% | -2,40 -2,60 7.66% | -5,12 -2,68 -91.04% | -2,61 -3,36 22.36% | -1,87 -3,11 39.83% | -2,61 -2,54 -2.91% | -5,76 -2,69 -114.34% | -2,18 -2,82 22.76% | 13,5 5,41 148.63% | -3,14 | -3,19 | -3,11 | -3,91 | -4,05 |
|
Net income Million USD | Released Forecast Spread | -3,57 -2,98 -19.45% | -2,40 -2,60 7.66% | -5,12 -2,68 -91.04% | -2,50 -3,36 25.72% | -1,87 -3,11 39.83% | -2,61 -2,54 -2.91% | -6,29 -2,69 -134.09% | -2,27 -2,82 19.56% | 13,5 5,41 148.63% | -3,14 | -3,19 | -3,11 | -3,91 | -4,05 |
|
EPS USD | Released Forecast Spread | -97,2 -84,6 -14.89% | -64,8 -72,0 10% | -54,3 -37,4 -45.07% | -15,8 -22,1 28.57% | -9,00 -14,1 36.03% | -7,11 -10,0 29.04% | -8,01 -3,18 -151.89% | -3,51 | 3,42 2,48 38.18% | -0,81 | -0,78 | -0,75 | -0,77 | -0,63 |
| Announcement Date | 08/07/22 | 12/08/22 | 09/11/22 | 23/03/23 | 09/05/23 | 08/08/23 | 09/11/23 | 25/03/24 | 10/05/24 | - | - | - | - | - |
More events
Past sector events for Kiora Pharmaceuticals, Inc.
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EYEG Stock
- Calendar Kiora Pharmaceuticals, Inc.
